Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Aptamer Group Share News (APTA)
APTA Share
Price
APTA Share
News
APTA Share
Chat
APTA Share
Trades6
APTA
Live RNS
APTA Share
Charts
APTA Level 2
Console
APTA Live
Share Price
APTA Broker
Ratings
APTA Directors
Deals
APTA Financial
Diary
APTA
Fundamentals
APTA Short
Positions
APTA
Media
APTA Company
Research
APTA Company
Timeline
Share Price Information for Aptamer Group (APTA)
Last checked at -
Last checked at 
Intraday Aptamer Group Share Chart
Aptamer reports decent technical, commercial progress
(Sharecast News) - Aptamer Group reported solid progress on both the technical and commercial fronts on Friday as it held its annual general meeting.
The AIM-traded firm said that since its recapitalisation in August, it had undergone a cost reduction initiative, streamlining production processes to boost capacity, and decreased material requirements from customers.
It also continued to expand and convert its commercial pipeline, with a recent partnership involving a genetic medicines company to advance Optimer development, facilitating targeted delivery of new medicines.
At 1121 GMT, shares in Aptamer Group were down 2.5% at 1.17p.
Reporting by Josh White for Sharecast.com.
Latest APTA News
- Aptamer signs development contract with biopharmaceutical firm
3 Jan 2025 - Aptamer strikes new development contract agreement
19 Dec 2024 - DIRECTOR DEALINGS: Helios Towers director buys GBP200,000 in shares
10 Dec 2024 - Aptamer appoints three new members to scientific board
6 Dec 2024 - EARNINGS AND TRADING: Synectics deal wins; TruFin to beat expectations
5 Dec 2024 - Aptamer reports progress since July fundraise
29 Nov 2024 - UK shareholder meetings calendar - next 7 days
22 Nov 2024 - AIM WINNERS & LOSERS: Fadel lowers forecasts on contract setbacks
7 Nov 2024
Related News
WINNERS & LOSERS: Diales earnings rise; Mirriad warns of liquidation
(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Thursday.
TRADING UPDATES: LPA to meet consensus; Aptamer raises GBP4.28 million
(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Thursday and not separately reported by Alliance News...
EARNINGS AND TRADING: Pennpetro eyes Texas well restart as oil rises
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately report...
Aptamer Group News
Aptamer signs development contract with biopharmaceutical firm
(Alliance News) - Aptamer Group PLC on December 19 said it signed a new development contract with a rare disease biopharmaceutical company.
Aptamer strikes new development contract agreement
(Sharecast News) - Life sciences group Aptamer has struck a new development contract agreement with a rare disease biopharmaceutical company worth up ...
DIRECTOR DEALINGS: Helios Towers director buys GBP200,000 in shares
(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Monday and Tuesday and no...
Aptamer appoints three new members to scientific board
(Sharecast News) - Aptamer Group announced the appointment of three new members to its scientific advisory board on Friday, as it advanced the commerc...
EARNINGS AND TRADING: Synectics deal wins; TruFin to beat expectations
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:
Aptamer reports progress since July fundraise
(Sharecast News) - Aptamer Group, the developer of 'Optimer' binders for the life sciences industry, flagged solid operational progress in an update o...
AIM WINNERS & LOSERS: Fadel lowers forecasts on contract setbacks
(Alliance News) - The following stocks are the leading risers and fallers on AIM on Thursday.
Follow the stocks
